{
    "clinical_study": {
        "@rank": "164669", 
        "arm_group": [
            {
                "arm_group_label": "ascorbic acid", 
                "arm_group_type": "Experimental", 
                "description": "ascorbic acid 2g in normal saline 500ml IV start 2hours before the operation"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Normal saline 500ml IV infusion for 2hour"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators want to know whether the intravenous ascorbic acid would reduce the blood\n      loss during laparoscopic myoma surgery. The investigators randomized patients into\n      intravenous ascorbic acid group and placebo group and examined the blood loss in both\n      groups."
        }, 
        "brief_title": "Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Uterine Leiomyoma", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Leiomyoma", 
                "Myofibroma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  uterine myoma\n\n          -  be planning to laparoscopic myomectomy\n\n          -  images ; the number of myoma <4\n\n          -  images ; the diameter of the largest myoma <9cm\n\n        Exclusion Criteria:\n\n          -  be planning other surgery in addition to laparoscopy\n\n          -  clinically significant coagulation abnormality"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01715597", 
            "org_study_id": "SNUBH_GO_016"
        }, 
        "intervention": {
            "arm_group_label": "ascorbic acid", 
            "description": "ascorbic acid 2g in normal saline 500ml IV start 30min before the operation and infusion for 2 hour", 
            "intervention_name": "ascorbic acid", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ascorbic Acid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "uterine leiomyoma", 
            "laparoscopic myomectomy", 
            "intraoperative blood loss", 
            "ascorbic acid"
        ], 
        "lastchanged_date": "December 24, 2013", 
        "location": {
            "contact": {
                "email": "kiding.kim.md@gmail.com", 
                "last_name": "kidong kim, M.D"
            }, 
            "facility": {
                "address": {
                    "city": "Gyeongg-ido", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy", 
        "other_outcome": [
            {
                "measure": "time of operation", 
                "safety_issue": "No", 
                "time_frame": "during laparoscopic myomectomy"
            }, 
            {
                "measure": "the amount of transfusion", 
                "safety_issue": "No", 
                "time_frame": "during laparoscopic myomectomy"
            }, 
            {
                "description": "postoperative day 1 hemoglobin - preoperative hemoglobin + hemoglobin increased by transfusion (hemoglobin 1 per RBC 1 pack transfusion)", 
                "measure": "the difference of hemoglobin", 
                "safety_issue": "No", 
                "time_frame": "postoperative day 1"
            }, 
            {
                "measure": "acute urinary retention", 
                "safety_issue": "No", 
                "time_frame": "2days after the operation"
            }
        ], 
        "overall_contact": {
            "email": "kidong.kim.md@gmail.com", 
            "last_name": "Kidong kim, M.D.", 
            "phone": "82-31-787-7262"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Bundang Hospital,Gyeongg-ido,Republic of Korea", 
            "last_name": "kiding kim, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Institutional Review Board", 
                "Korea: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "blood loss", 
            "safety_issue": "No", 
            "time_frame": "during  laparoscopic myomectomy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01715597"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Kidong Kim", 
            "investigator_title": "Assistant professor in department of OBGY", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}